News Daily News Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell November 11, 2016
News Daily News Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias Yael L. Maxwell November 11, 2016
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Conference News SCAI 2016 Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding L.A. McKeown May 05, 2016
News Daily News Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados Yael L. Maxwell April 25, 2016
News Daily News A Closer Look at Bleeding Avoidance Strategies in PCI Reveals Little Impact on Outcomes Yael L. Maxwell April 25, 2016
Presentation Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy Presenter: MB. Kadakia December 20, 2015
News Daily News Radial-Access Associated with One-Third Less Bleeding in Rescue PCI After Fibrinolysis Michael O'Riordan December 20, 2015
News Daily News Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI Todd Neale December 14, 2015
News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Daily News PCI Transradial podría atenuar los beneficios de la bivalirudina Todd Neale October 05, 2015
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
Presentation ESC 2015 Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program Presenter: Marco Valgimigli September 01, 2015
News Daily News El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina L.A. McKeown April 28, 2015